145 related articles for article (PubMed ID: 25963903)
1. Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.
Mohammadi-Yeganeh S; Mansouri A; Paryan M
Chem Biol Drug Des; 2015 Nov; 86(5):1185-91. PubMed ID: 25963903
[TBL] [Abstract][Full Text] [Related]
2. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
Mohammadi-Yeganeh S; Hosseini V; Paryan M
J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
5. miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer.
Kong P; Chen L; Yu M; Tao J; Liu J; Wang Y; Pan H; Zhou W; Wang S
Cell Death Dis; 2018 Oct; 9(11):1059. PubMed ID: 30333478
[TBL] [Abstract][Full Text] [Related]
6. The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L.
Guarnieri AL; Towers CG; Drasin DJ; Oliphant MUJ; Andrysik Z; Hotz TJ; Vartuli RL; Linklater ES; Pandey A; Khanal S; Espinosa JM; Ford HL
Oncogene; 2018 Jul; 37(28):3879-3893. PubMed ID: 29662198
[TBL] [Abstract][Full Text] [Related]
7. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
[TBL] [Abstract][Full Text] [Related]
8. miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
Shyamasundar S; Lim JP; Bay BH
Int J Oncol; 2016 Dec; 49(6):2629-2636. PubMed ID: 27840899
[TBL] [Abstract][Full Text] [Related]
9. miR-141 as potential suppressor of β-catenin in breast cancer.
Abedi N; Mohammadi-Yeganeh S; Koochaki A; Karami F; Paryan M
Tumour Biol; 2015 Dec; 36(12):9895-901. PubMed ID: 26164002
[TBL] [Abstract][Full Text] [Related]
10. A truncated-Flt1 isoform of breast cancer cells is upregulated by Notch and downregulated by retinoic acid.
Mezquita B; Mezquita J; Barrot C; Carvajal S; Pau M; Mezquita P; Mezquita C
J Cell Biochem; 2014 Jan; 115(1):52-61. PubMed ID: 23904188
[TBL] [Abstract][Full Text] [Related]
11. MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.
Zhang L; Ma P; Sun LM; Han YC; Li BL; Mi XY; Wang EH; Song M
Mol Carcinog; 2016 May; 55(5):768-77. PubMed ID: 25851994
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH
Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450
[TBL] [Abstract][Full Text] [Related]
13. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
14. miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.
Jiang L; Lin T; Xu C; Hu S; Pan Y; Jin R
J Cell Mol Med; 2016 Feb; 20(2):313-22. PubMed ID: 26612211
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
16. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
[TBL] [Abstract][Full Text] [Related]
17. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
18. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
19. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
20. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
Ren YQ; Fu F; Han J
Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
